Boston Research & Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.63M |
| 2 |
iShares US Consumer Staples ETF
IYK
|
+$713K |
| 3 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$594K |
| 4 |
iShares Preferred and Income Securities ETF
PFF
|
+$536K |
| 5 |
Equinix
EQIX
|
+$401K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BNY
Bank of New York Mellon
BNY
|
+$2.15M |
| 2 |
Walmart Inc
WMT
|
+$1.76M |
| 3 |
VanEck Biotech ETF
BBH
|
+$1.73M |
| 4 |
iShares Biotechnology ETF
IBB
|
+$1.58M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.48M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.75% |
| 2 | Healthcare | 12.01% |
| 3 | Financials | 10.55% |
| 4 | Consumer Staples | 10.22% |
| 5 | Industrials | 9.81% |
Similar funds
Boston Research & Management's Q4 2025 Portfolio in Review
As of Q4 2025, Boston Research & Management held 124 positions worth $434M, down 4.3% from $453M the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Boston Research & Management withdrew a net $23.7M in Q4 2025, closing 4 positions and reducing 61 holdings. Its most notable exit was VanEck Biotech ETF, an estimated $1.73M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Boston Research & Management opened a new position in iShares US Consumer Staples ETF worth $702K.
- Boston Research & Management's largest Q4 2025 buy was iShares US Consumer Staples ETF: 10,500 shares worth $702K.
- Boston Research & Management added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $1.63M increase.
- Boston Research & Management's biggest Q4 2025 reduction was Bank of New York Mellon, cutting an estimated $2.15M.
- Boston Research & Management fully exited VanEck Biotech ETF in Q4 2025, selling an estimated $1.73M.
- Boston Research & Management's ten largest holdings make up 31% of its $434M portfolio in Q4 2025.
- Boston Research & Management opened 5 new positions and closed 4 in Q4 2025.
- Boston Research & Management's portfolio value fell 4.3% quarter-over-quarter to $434M.
Based on Boston Research & Management's 13F filing for Q4 2025, filed 11 Feb 2026.